Prestige Consumer Healthcare (PBH) Invested Capital (2011 - 2026)

Prestige Consumer Healthcare has reported Invested Capital for 16 years, with the latest figure at $2.9 billion in Q1 2026.

• On a quarterly basis, Invested Capital rose 1.92% year-over-year to $2.9 billion in Q1 2026; TTM through Mar 2026 was $2.9 billion, a 1.92% increase from a year earlier, with the FY2026 full-year figure at $2.9 billion, up 1.92% from the prior year.
• Invested Capital was $2.9 billion for Q1 2026 at Prestige Consumer Healthcare, up from $2.9 billion in the prior quarter.
• The five-year high for Invested Capital was $3.1 billion in Q4 2022, with the low at $2.8 billion in Q2 2024.
• Average Invested Capital over 5 years is $2.9 billion, with a median of $2.8 billion recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Invested Capital grew 7.62% in 2022, then declined 10.0% in 2023.
• Over 5 years, Invested Capital stood at $3.1 billion in 2022, then fell by 10.0% to $2.8 billion in 2023, then decreased by 0.7% to $2.8 billion in 2024, then gained by 2.97% to $2.9 billion in 2025, then advanced by 0.65% to $2.9 billion in 2026.
• The last three Invested Capital figures came in at $2.9 billion (Q1 2026), $2.9 billion (Q4 2025), and $2.8 billion (Q3 2025), per Business Quant data.